We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$18.5B
AUM Growth
-$190M
(-1%)
Cap. Flow
-$476M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
23.36%
Holding
1,444
New
113
Increased
518
Reduced
506
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$111M |
| 2 |
Synchrony
SYF
|
+$88.9M |
| 3 |
NVR
NVR
|
+$79.4M |
| 4 |
Target
TGT
|
+$74.1M |
| 5 |
Incyte
INCY
|
+$66.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$102M |
| 2 |
Zoetis
ZTS
|
+$70.6M |
| 3 |
Illumina
ILMN
|
+$61.3M |
| 4 |
McDonald's
MCD
|
+$58.7M |
| 5 |
Adobe
ADBE
|
+$57.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.01% |
| 2 | Financials | 14.75% |
| 3 | Consumer Discretionary | 13.36% |
| 4 | Healthcare | 12.04% |
| 5 | Industrials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Rigel Pharmaceuticals
RIGL
$762M
| $329K | ﹤0.01% |
17,590
| – | – |
|
1102
Alnylam Pharmaceuticals
ALNY
$30.4B
| $328K | ﹤0.01% |
4,081
-1,040
| -20% | -$82.3K |
|
1103
York Water
YORW
$528M
| $328K | ﹤0.01% |
7,519
+1,100
| +17% | +$41.5K |
|
|
BHVN
1104
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $328K | ﹤0.01% |
+7,850
| New | +$332K |
|
1105
Univest Financial
UVSP
$1.18B
| $327K | ﹤0.01% |
12,825
+3,860
| +43% | +$99.9K |
|
|
PDCE
1106
DELISTED
PDC Energy, Inc.
PDCE
| $327K | ﹤0.01% |
+11,766
| New | +$353K |
|
1107
Moog Inc Class A
MOG.A
$13.6B
| $326K | ﹤0.01% |
4,022
+240
| +6% | +$20.4K |
|
1108
Allegiant Air
ALGT
$2.36B
| $325K | ﹤0.01% |
2,173
+180
| +9% | +$26.4K |
|
1109
Gorman-Rupp
GRC
$2.15B
| $325K | ﹤0.01% |
9,348
-100
| -1% | -$3.18K |
|
1110
Neurocrine Biosciences
NBIX
$15.9B
| $322K | ﹤0.01% |
3,570
-14,380
| -80% | -$1.34M |
|
|
BPFH
1111
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $321K | ﹤0.01% |
27,577
-8,700
| -24% | -$98K |
|
|
BID
1112
DELISTED
Sotheby's
BID
| $316K | ﹤0.01% |
5,548
| – | – |
|
1113
Xerox
XRX
$412M
| $314K | ﹤0.01% |
+10,508
| New | +$329K |
|
1114
Veracyte
VCYT
$3.59B
| $313K | ﹤0.01% |
13,035
+1,500
| +13% | +$39.9K |
|
1115
Primoris Services
PRIM
$4.39B
| $311K | ﹤0.01% |
+15,855
| New | +$317K |
|
|
PLAN
1116
DELISTED
Anaplan, Inc.
PLAN
| $311K | ﹤0.01% |
6,610
-3,090
| -32% | -$168K |
|
|
QADA
1117
DELISTED
QAD Inc.
QADA
| $309K | ﹤0.01% |
6,685
| – | – |
|
|
BEAT
1118
DELISTED
BioTelemetry, Inc.
BEAT
| $308K | ﹤0.01% |
7,553
| – | – |
|
1119
First Citizens BancShares
FCNCA
$25.6B
| $307K | ﹤0.01% |
+651
| New | +$296K |
|
1120
Ethan Allen Interiors
ETD
$575M
| $306K | ﹤0.01% |
16,015
-1,320
| -8% | -$25.1K |
|
1121
DXP Enterprises
DXPE
$3.04B
| $305K | ﹤0.01% |
8,797
+600
| +7% | +$20.2K |
|
1122
Urban Outfitters
URBN
$6.63B
| $305K | ﹤0.01% |
10,855
-190
| -2% | -$4.43K |
|
|
SGI
1123
Somnigroup International
SGI
$13.5B
| $303K | ﹤0.01% |
+15,712
| New | +$301K |
|
|
DOCU
1124
DocuSign
DOCU
$12.2B
| $300K | ﹤0.01% |
+4,850
| New | +$254K |
|
1125
Chemours
CC
$2.29B
| $298K | ﹤0.01% |
19,946
+1,430
| +8% | +$23.3K |
|
Similar funds
WP
N
PCH
Los Angeles Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Los Angeles Capital Management held 1,444 positions worth $18.5B, down 1% from $18.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Los Angeles Capital Management's Q3 2019 filing shows 113 new, 518 increased, 506 reduced and 185 closed positions. Its largest new stake was Vulcan Materials: 399,564 shares worth $60.4M. The largest sale was Amazon, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Los Angeles Capital Management's largest Q3 2019 buy was Vulcan Materials: 399,564 shares worth $60.4M.
- Los Angeles Capital Management added most to AbbVie in Q3 2019, an estimated $111M increase.
- Los Angeles Capital Management's biggest Q3 2019 reduction was Amazon, cutting an estimated $102M.
- Los Angeles Capital Management fully exited Total System Services, Inc. in Q3 2019, selling an estimated $32.3M.
- Los Angeles Capital Management's ten largest holdings make up 23% of its $18.5B portfolio in Q3 2019.
- Los Angeles Capital Management opened 113 new positions and closed 185 in Q3 2019.
- Los Angeles Capital Management's portfolio value fell 1% quarter-over-quarter to $18.5B.
Based on Los Angeles Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.